Columbus Venture Partners prepares new investment fund for biotech companies to be ready in 2019
Columbus Venture Partners prepara un nuevo fondo de inversión para empresas biotecnológicas operativo en 2019
Intel ID : 250314
| Intel ID | 250314 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Columbus Venture Partners
(31 Dec 2023) |
Revenue: EUR 6,71m EBITDA: EUR 4,58m People: 15 |
|
| Date |
 |
|
| Country | |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
 |
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
25.01.10 Venture Capital 25 Financial Services / 25.01 Banking & Investment |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.